Analyst Ratings for [RXST] RxSight, Inc.

7/15/25	Downgrades	Overweight Eq-Weight	X
RXST RxSight Morgan Stanley
$9
7/10/25	Downgrades	Buy Hold	X
RXST RxSight Jefferies
$9
7/9/25	Downgrades	Buy Neutral	X
RXST RxSight BTIG Research
7/9/25	Downgrades	Outperform Perform	X
RXST RxSight Oppenheimer
7/9/25	Downgrades	Overweight Eq Weight	X
RXST RxSight Wells Fargo
$9
5/19/25	Upgrades	Eq Weight Overweight	X
RXST RxSight Wells Fargo
$25
4/15/25	Initiated	Neutral	X
RXST RxSight Piper Sandler
$18
4/9/25	Downgrades	Buy Neutral	X
RXST RxSight UBS
$16
4/4/25	Downgrades	Overweight Underweight	X
RXST RxSight JP Morgan
$40 $17
4/3/25	Downgrades	Buy Underperform	X
RXST RxSight BofA Securities
$36 $22
12/20/24	Downgrades	Buy Hold	X
RXST RxSight Stifel
$65 $40
12/11/24	Downgrades	Overweight Eq Weight	X
RXST RxSight Wells Fargo
$56 $42
12/6/24	Initiated	Buy	X
RXST RxSight UBS
$52
10/29/24	Initiated	Buy	X
RXST RxSight Jefferies
$72
8/20/24	Reiterated	Buy	X
RXST RxSight Needham
$54 $66
8/6/24	Reiterated	Buy	X
RXST RxSight Needham
$75 $54
5/7/24	Reiterated	Buy	X
RXST RxSight BTIG Research
$61 $72
12/13/23	Upgrades	Eq Weight Overweight	X
RXST RxSight Wells Fargo
$31 $42
12/12/23	Initiated	Buy	X
RXST RxSight Stifel
$40
12/4/23	Initiated	Overweight	X
RXST RxSight Morgan Stanley
$36
4/13/23	Initiated	Outperform	X
RXST RxSight Oppenheimer
$23
12/12/22	Downgrades	Overweight Eq Weight	X
RXST RxSight Wells Fargo
$20 $14

RXST RxSight, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.